Felice Schnoll-Sussman, MD MSc
Dr. Felice Schnoll-Sussman is a Professor of Clinical Medicine in the Division of Gastroenterology at Weill Cornell Medicine and Chair of the Board of the American Foregut Society. She serves as Director of the Jay Monahan Center for Gastrointestinal Health, Associate Chief of Medicine for Network and Outreach Development at NewYork-Presbyterian Brooklyn Methodist Hospital, and Director of Outreach for the Weill Cornell Department of Medicine.
Dr. Schnoll-Sussman’s clinical and research interests focus on the diagnosis and treatment of esophageal and swallowing disorders, including gastroesophageal reflux disease, Barrett’s esophagus, eosinophilic esophagitis, achalasia, and esophageal cancer. She is the founder of DIGEST (Dedicated Integrated GastroEsophageal Treatment), a multidisciplinary program at Weill Cornell/NewYork-Presbyterian that provides a novel, integrated approach to the care of patients with complex esophageal disease.
She has held numerous national and regional leadership roles, including former Director of Endoscopy at Weill Cornell Medicine, Governor of the American College of Gastroenterology, Co-Director of the New York City Colon Cancer Control Coalition, and President of the New York Society for Gastrointestinal Endoscopy. Dr. Schnoll-Sussman is a co-author of the most recent national GERD guidelines for the American College of Gastroenterology.
An eleven-time Castle Connolly Top Doctor awardee, Dr. Schnoll-Sussman is a passionate advocate for esophageal, colorectal, and pancreatic cancer awareness and prevention. She also serves on the boards of Let’s Win, AliveAndKick’n, and Temple Israel of New York, reflecting her deep commitment to patient advocacy, community engagement, and cancer awareness beyond the clinical setting.
Financial relationships
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:MedtronicTopic:Barrett'sDate added:01/31/2026Date updated:01/31/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:SebelaTopic:GERDDate added:01/31/2026Date updated:01/31/2026

Facebook
X
LinkedIn
Forward